Table 5 Analysis of risk factors of relapse among study participants
Variables | Relapsed | Non relapsed | OR | 95% CI | ||
|---|---|---|---|---|---|---|
n | % | n | % | |||
Treatment group | ||||||
TBI/Cy | 9 | 11.5 | 69 | 88.5 | 0.356 | 0.134–0.948 |
Bu/Cy | 11 | 26.8 | 30 | 73.2 | ||
Donor/recipient sex matching | ||||||
Mismatch | 15 | 20.5 | 58 | 79.5 | 2.121 | 0.714–6.297 |
Matching | 5 | 10.9 | 41 | 89.1 | ||
Age in years | ||||||
< 30 | 12 | 16.4 | 61 | 83.6 | 0.934 | 0.350–2.495 |
> 30 | 8 | 17.4 | 38 | 82.6 | ||
Phenotype | ||||||
B | 11 | 13.9 | 68 | 86.1 | 0.557 | 0.210–1.482 |
T | 9 | 22.5 | 31 | 77.5 | ||
Philadelphia chromosome status | ||||||
Negative | 15 | 16.3 | 77 | 83.7 | 0.857 | 0.280–2.621 |
Positive | 5 | 18.5 | 22 | 81.5 | ||
Disease status at transplant | ||||||
CR 1 | 6 | 10.7 | 50 | 89.3 | 0.420 | 0.149–1.182 |
≥ CR 2 | 14 | 22.2 | 49 | 77.8 | ||
Recipient sex | ||||||
Females | 12 | 14.0 | 74 | 86.0 | 0.507 | 0.186–1.382 |
Males | 8 | 24.2 | 25 | 75.8 | ||